Industrial and Academic Neglected Disease Drug Discovery Collaborations: GSK and Northeastern University

Hear how Dr. Julio Martin (GSK) and Dr. Michael Pollastri (Northeastern) are leveraging the neglected disease community for drug discovery collaborations.

 

Julio Martin and his colleagues at the Tres Cantos GSK Open Laboratory are working collaboratively on diseases like African Sleeping Sickness, Chagas Disease, Leishmaniasis, Tuberculosis, and Malaria in an industrial environment.   Michael Pollastri brings big pharma experience to multi-center academic collaborations.  Their experiences are relevant for both commercial and neglected disease drug discovery.  They are both experimenting while pushing boundaries in new modes combining sensitive and open data.   Learn about GSK and Northeastern’s work directly together, and separately with dozens of leading researchers around the world.    These unique approaches to collaboration and science suggest a more efficient paradigm that one day may become the status quo.  Come to the webinar with your own questions and to hear what can we learn from their new modes of collaboration.

Register Now!

Date:

  • Wednesday, June 28th, 2017
  • 17:00 (GMT), 11:00 (US Eastern), 8:00 (US Pacific)

Speakers:

   

  • Julio Martin, Head of Kinetoplastid Biology, Director & GSK Fellow, GSK R&D, Tres Cantos, Spain
  • Michael Pollastri, Associate Professor & Chair of Chemistry & Chemical Biology, Northeastern University, Boston, Massachusetts

Join our distinguished panel of speakers as they deviate from the expected “PowerPoint presentation” style webinar to provide an engaging Town Hall experience.

Register Now to reserve your attendee slot!


Big thanks to our sponsors for allowing us to freely share these timely updates!

Lab Launch      MolPort     wega_logo_300                       SCIENTIST

 

also thanks to the Research Data Alliance.


This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities.

CDD Vault: Drug Discovery Informatics your whole project team will embrace